Saloustros E, Mavroudis D. Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis. Future Oncol. 2010;6:209-19 pubmed publisher
..Prospective clinical trials are warranted in order to validate the use of CTCs as predictive and/or prognostic markers and assess their utility in individualizing therapy of patients with early breast cancer. ..
Saloustros E, Salpea P, Qi C, Gugliotti L, Tsang K, Liu S, et al. Hematopoietic neoplasms in Prkar2a-deficient mice. J Exp Clin Cancer Res. 2015;34:143 pubmed publisher
..Prkar2a deficiency predisposes to hematopoietic malignancies in vivo. RIIÎ±'s likely association with HS and DLBCL was hitherto unrecognized and may lead to better understanding of these rare neoplasms. ..